Growth Metrics

Sonoma Pharmaceuticals (SNOA) Short-Term Debt repayments (2021 - 2023)

Sonoma Pharmaceuticals has reported Short-Term Debt repayments over the past 3 years, most recently at $129000.0 for Q3 2023.

  • For Q3 2023, Short-Term Debt repayments fell 43.91% year-over-year to $129000.0; the TTM value through Sep 2023 reached $719000.0, changed N/A, while the annual FY2022 figure was $30000.0, 93.76% down from the prior year.
  • Short-Term Debt repayments for Q3 2023 was $129000.0 at Sonoma Pharmaceuticals, down from $130000.0 in the prior quarter.
  • Over five years, Short-Term Debt repayments peaked at $230000.0 in Q2 2022 and troughed at $129000.0 in Q3 2023.
  • A 3-year average of $183600.0 and a median of $199000.0 in 2021 define the central range for Short-Term Debt repayments.
  • Biggest five-year swings in Short-Term Debt repayments: grew 15.58% in 2022 and later tumbled 43.91% in 2023.
  • Year by year, Short-Term Debt repayments stood at $199000.0 in 2021, then rose by 15.58% to $230000.0 in 2022, then tumbled by 43.91% to $129000.0 in 2023.
  • Business Quant data shows Short-Term Debt repayments for SNOA at $129000.0 in Q3 2023, $130000.0 in Q2 2023, and $230000.0 in Q3 2022.